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a  b  s  t  r  a  c  t
Introduction: Antiretroviral therapy and prophylaxis during the antepartum, intrapartum and
postpartum periods, cesarean delivery and avoidance of breast milk signiﬁcantly reduce
vertical transmission of HIV.
Objective: To evaluate the effectiveness prevention of mother-to-child transmission of HIV
and  determine the rate of vertical transmission in a public sexually transmitted infection
and HIV referral center in Salvador, Bahia, in the period immediately prior to the initiation
of  universal antiretroviral therapy in pregnant women.
Methods: Cross-sectional study using data collected from medical records of children born to
HIV  infected mothers in Bahia from 2005 to 2008 who were referred to the Reference Center
for  Diagnosis and Research of Sexually Transmitted Diseases and HIV/AIDS for care.
Results: Of 232 HIV-exposed infants, 19 (8.2%) had conﬁrmed HIV infection. One hundred
eighty-eight (81%) mothers received antenatal care, 120 (52%) antepartum antiretroviral
therapy or prophylaxis, and 168 (72%) intrapartum zidovudine. Two hundred twenty-three
(96%)  infants received zidovudine. In multivariable models, the combination of intrapartum
and postpartum antiretroviral prophylaxis was associated with decreased adjusted odds of
mother-to-child transmission.
Conclusions: Low levels of antenatal screening and access to prevention of mother-to-childtransmission were signiﬁcant limitations in the cascade of prevention of mother-to-child
transmission at our center in this period.
© 2015 Elsevier Editora Ltda. All rights reserved.∗ Corresponding author at: Global Health Sciences, University of Califo
Francisco, CA 941543-1224, USA.
E-mail address: george.rutherford@ucsf.edu (G.W. Rutherford).
http://dx.doi.org/10.1016/j.bjid.2015.06.006
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ntroduction
lthough there has been a global decline in incident HIV
nfection worldwide, this has been less pronounced in Latin
merica.1 Within Latin America, Brazil accounts for 47% of
ll people living with HIV.1 Brazil has a mixed epidemic with
eterosexuals, injection drug users, and men  who have sex
ith men  predominating in different areas of the country.2 In
ortheastern Brazil, where heterosexual transmission is the
ost common route of transmission, there is a substantial
urden of HIV infection in infants.3
Worldwide progress in stopping new HIV infections among
hildren has been dramatic. In 2013, 240 000 children were esti-
ated to be newly  infected with HIV.1 This is 58% lower than in
002, the year with the highest incidence, when 580 000 chil-
ren were newly  infected. Providing access to antiretroviral
rugs to pregnant women living with HIV has averted more
han 900 000 new HIV infections among children since 2009.1
hese declines have been due in large part to improved pre-
ention technology, including widespread antenatal screening
or HIV, suppressive antiretroviral prophylaxis and therapy,
se of cesarean sections, and avoidance of breast feeding.4 In
articular, the use of antiretroviral drugs to prevent mother-
o-child transmission (MTCT) has expanded massively since
he ﬁrst reports of zidovudine (ZDV) prophylaxis, and many
ountries have initiated programs to prevent HIV vertical
ransmission with the result that today MTCT rates of HIV
nfection are as low as 1% in developed countries and <5%
n developing countries.5,6
In 1996, the Brazilian government began a national pro-
ram of free access to antiretroviral therapy (ART) and
omprehensive HIV prevention that included mandatory ante-
atal HIV testing for pregnant women. Subsequently, in a
ationwide multicenter study, Succi showed that MTCT rates
ere around 7%, ranging from 6% in the South and Central-
est to 15% in the Northern Region.7,8 These rates could reach
s little as 1% if all the Ministry of Health recommendations
o avoid vertical transmission of HIV were fully adopted.9
We  present in this study an evaluation of PMTCT at a major
enter in the state of Bahia in northeastern Brazil, where het-
rosexual transmission is the predominant form of infection
n adults.
ethods
e  conducted a registry-based cross-sectional study of
IV-infected mothers and their infants to evaluate the
ffectiveness of the program for prevention of MTCT
PMTCT) at the Reference Center for Diagnosis and Research
f Sexually Transmitted Diseases and HIV/AIDS of the
tate of Bahia (CEDAP). CEDAP provided care for 63.3%
f HIV-infected pregnant women in Bahia during the
tudy period. We  analyzed data collected in the period
f 2005–2008. This corresponds to the period in which all
ata were centralized in CEDAP. The standard of prac-
ice for PMTCT during the study period was deﬁned
y Brazilian national PMTCT guidelines9 and included
niversal antenatal screening for HIV, antiretroviral5;1 9(5):538–542 539
prophylaxis for both mothers and newborns, and provision of
free formula to avoid exposure through breast milk.
Study  population
We  included all children aged 0–36 months old born to HIV-
infected mothers residing in Bahia during the study period
who received their care through CEDAP. All children included
in the study had at least two viral load determinations accord-
ing to the surveillance deﬁnition for vertically transmitted HIV
in Brazil.10
Data  collection
Data were collected from CEDAP’s electronic medical record
system. This system, called SMART, stores and manages infor-
mation collected at each patient visit. We extracted data from
medical, surveillance, and laboratory records, including demo-
graphic data and epidemiological data related to HIV infection
and sexually transmitted infections (STI), clinical evaluations,
biochemical and hematological values, HIV  serology and HIV
viral load.
Our primary outcome variable was HIV  infection. A child
was considered HIV-infected if he or she had two detectable
positive viral load tests at different times. A child status was
considered negative if he or she presented two or more  unde-
tectable viral loads at 6 weeks of age or later.
Data  analysis
We  constructed a data bank and analyzed our data using
STATA version 11 (STATA Corporation, College Station, TX,
USA). Our principal outcome variable was conﬁrmed HIV
infection in infants. We  examined associations with con-
ﬁrmed infection by calculating odds ratios and testing for
signiﬁcance using the 2 test. In order to select the best model
we used the Akaike information criterion (AIC) for goodness
of ﬁt.11 We examined the independent contribution of predic-
tor variables by constructing a multivariate logistic regression
model.
Ethical  considerations
This project was approved by the Research Ethics Committee
of the Bahia Ministry of Health.
Results
Of the 622 children who were born to HIV-infected mothers
at CEDAP between 2005 and 2008, 172 (28%) did not meet
our eligibility criteria because these children were seen one
or fewer times in the health service, leaving 450 eligible
infants. Of these, 232 (52%) children had two  or more  viral
loads and were available for analysis. One hundred eighty-
eight (81%) women received antenatal care, 120 (52%) received
antiretroviral prophylaxis during the antepartum period, and
168 (72%) received intravenous zidovudine (ZDV) during the
intrapartum period. Two hundred twenty-three (96%) infants
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Table 1 – Factors associated with mother-to-child HIV transmission, Bahia, Brazil, 2005–2008.
Characteristics Total Infected Uninfected Bivariate Multivariate*
(n = 232) (n = 19) (n = 213) OR (95% CI) aOR (95% CI)
n (%) n (%)
District
Salvador 160 (69.0) 17 (89.5) 143 (67.1) 4.16 (0.94–37.95) 4.63 (0.93–23.10)
Other areas 72 (31.0) 2 (10.5) 70 (32.9)
Pre-natal care
Yes 188 (81.0) 12 (63.2) 176 (82.6) 0.36 (0.14–0.95) 0.77 (0.24–2.46)
No 44 (19.0) 7 (36.8) 37 (17.4)
Antepartum ART
Yes 120 (51.7) 4 (21.1) 116 (54.5) 0.22 (0.08–0.66) 0.73 (0.13–4.12)
No 112 (48.3) 15 (78.9) 97 (45.5)
Intrapartum ART
Yes 168 (72.4) 7 (36.8) 161 (75.6) 0.19 (0.07–0.49) –
No 64 (27.6) 12 (63.2) 52 (24.4)
Typeofdelivery
Vaginal 77 (33.2) 10 (52.6) 67 (31.5) 2.42 (0.96–6.08) 0.47 (0.12–1.80)
Cesarean 155 (66.8) 9 (47.4) 146 (68.1)
Membranes at presentation
Ruptured 77 (33.2) 8 (42.1) 69 (32.4) 1.52 (0.60–3.84) 0.70 (0.23–2.16)
Intact 155 (66.8) 11 (57.9) 144 (67.6)
Breastfed
Yes 222 (95.7) 18 (94.7) 204 (95.8) 1.25 (0.00–8.27) 0.30 (0.02–4.41)
No 10 (4.3) 1 (5.3) 9 (4.2)
Postpartum ZDV
Yes 22 (9.5) 16 (84.2) 6 (2.8) 0.24 (0.05–1.22) –
No 210 (90.5) 3 (15.8) 207 (97.2)
Complete PMTCT prophylaxis**
All 96 (41.4) 2 (10.5) 94 (44.1) 0.15 (0.00–0.60) 0.27 (0.03–2.80)
Partial 136 (58.6) 17 (89.5) 119 (55.9)
Intrapartum and postpartum ZDV
None 7 (3.0) 3 (15.8) 4 (1.9)
Intrapartum 2 (0.9) 0 (0) 2 (0.9) – –
Postpartum 57 (24.6) 9 (47.4) 48 (22.5) 0.25 (0.05–1.3) 0.12 (0.02–0.86)
Both 166 (71.6) 7 (36.8) 159 (74.6) 0.06 (0.01–0.31) 0.04 (0.00–0.35)
aOR, adjusted odds ratio; ART, antiretroviral therapy; CI, conﬁdence interval; PMTCT, prevention of mother-to-child HIV transmission; ZDV,
zidovudine.
∗ Akaike information criterion for goodness of ﬁt, 127.3142.
∗∗ Use of antenatal ART, intrapartum ZDV and postpartum oral ZDV.received postexposure ZDV prophylaxis. Ten (4.3%) mothers
reported breastfeeding.
Nineteen (8.2%) of the 232 infants were infected (Table 1).
Receiving antiretroviral prophylaxis in the antepartum and
intrapartum periods was signiﬁcantly associated with lower
risk of transmission. The greatest reduction in transmission
was among mother-infant pairs in which the mother received
intravenous ZDV during labor and delivery and the infants
received post-exposure oral ZDV (odds ratio [OR] 0.06, 95% con-
ﬁdence interval [CI] 0.01–0.31) (Table 1). Delivery by cesarean
section was not signiﬁcantly associated with transmission (OR
2.42, 95% conﬁdence interval 0.96–6.08).In multivariate logistic regression, we  found that the com-
bination of intrapartum ZDV in the mother and provision of
ZDV to the infant had the lowest adjusted odds of transmis-
sion (adjusted OR [aOR] 0.04, 95% CI 0.00–0.35). Prophylaxis innewborns alone also independently predicted lack of trans-
mission (aOR 0.12, 95% CI 0.02–0.86).
Discussion
We found that the rate of MTCT in the principal public-sector
provider in Bahia in the period 2005–2008 was 8.2%, which
is substantially higher than rates that have been achieved
in other parts of Brazil.12 This period was characterized by
suboptimal coverage of antenatal HIV screening and antepar-
tum prophylaxis, suggesting that as these components of the
PMTCT achieve greater coverage, transmission rates should
fall as well. More recent national-level data on screening
and prophylaxis in Brazil have associated improvements
in the national PMTCT program with signiﬁcant declines



























































during the years 2000 and 2001: results of a multi-centricb r a z j i n f e c t d i s .
n transmission rates.9 We  were also able to conﬁrm that the
ombination of intrapartum and postpartum ZDV prophylaxis
as associated with decreased adjusted odds of transmission
n this real-world setting, as was infant post-partum prophy-
axis alone.
The impact of the PMTCT on the prevalence of vertical
ransmission of HIV infection varies signiﬁcantly among the
ifferent regions of Brazil.3,13 In São Paulo the rates of peri-
atal transmission of HIV infection among babies born to
IV-infected mothers fell from 16% in 1995 to 2.7% in 2006.6
n Goiás, a large state in the central region, 70 (21%) of 332
IV-exposed children were infected in the period 1995 to
001.14 In a multicenter study conducted in Brazil in 2000,
ncluding states from the ﬁve largest regions of the coun-
ry, rates of vertical transmission varied between 4.9% to
7.6% with the highest rate in the North of the country. Inter-
stingly, HIV MTCT rates among women with and without
ntenatal care were 6.5% and 28.7%, respectively, and fell to
etween 5.6% and 18.0% in 2001.7 Sentinel surveillance in
razil in 2002 clearly indicated regional inconsistencies in
ffering HIV testing to pregnant women during antenatal care
r even at delivery, varying from 24% in the Northeast to 72%
n the South. Overall, the coverage of antenatal HIV testing
n this study was only 52%.15 An earlier Brazilian study of
he effectiveness of intrapartum and postpartum ZDV pro-
hylaxis found results similar to ours, with risk of MTCT in
ampinas decreasing from 32.2% to 2.9% after the PACTG 076
rotocol was implemented.16 The MTCT rate in the State of
ernambuco was 9.2%17 very similar to a rate of 9.9% recorded
n Manaus, in the northern region, between 2007 and 2009.18
ne study in Rio Grande do Sul between 2003 and 2007 found a
ransmission rate of 4.8%, and the decline over the years was
ttributed to the successful control of factors, which causes
eripartum and postnatal transmission.19
Our study has signiﬁcant limitations. First, because we
equired two negative viral tests for a child to be deﬁned
s uninfected, we had substantial missing data and were
nly able to study a sub-sample of all HIV-exposed infants
eported through CEDAP during this time period. If all exposed
regnancies had been detected, the transmission rate we
bserved may well have been different from what would have
een found if complete data were available both because of
ncreased power as well as the potential for non-random
issingness. Secondly, the study was dependent on medical
ecords and surveillance data, with problems of data qual-
ty and completeness. Finally, while CEDAP provided care
or approximately two-thirds of all HIV-infected pregnant
omen in Bahia, our sample is not representative of the
ntire state. Inclusion of patient from other referral centers
nd from more  rural areas may well have led to different
esults.
Nonetheless, within the constraints of the data available
o us, we  believe that we  have a reasonable estimate of cov-
rage of critical PMTCT interventions in the major referral
enter in Bahia during this period. Additional effort needs to be
ade to improve data collection system to assure a more  com-
lete sample of the universe of exposed infants born in Bahia.
ssuring universal antenatal screening and access to PMTCT
efore pregnant HIV-infected women present in labor have
mproved in Bahia, especially as the Brazilian government5;1 9(5):538–542 541
implements its new strategy of universal life-long ART at diag-
nosis, including for pregnant women.20
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